After seven years of hard work, Cherian Verghese has discovered new results in a study on Follicular Lymphoma, a type of ...

Follicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment ...

Follicular Lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rate of more than 10 years.

Cancer survivors may experience anxiety over minor illnesses, fearing recurrence despite being in remission. The "positivity trap" can make survivors feel invalidated, as constant reassurance may ...

SEATTLE – March 4, 2026 – Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. Cancer Action Plan of Washington (CAPOW) packs a punch The new ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades. Yet up to 20% of patients develop early progression after starting ...

Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy Patients with previously untreated ...

"Histological transformation of FL to DLBCL was a low‐incidence event associated with distinct clinical features and inferior survivals . . . By population‐based analysis and external validation, ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to epcoritamab-bysp for the treatment of adults with relapsed or refractory ...

Monjuvi in combination with lenalidomide and rituximab significantly improved PFS in patients with relapsed/refractory follicular lymphoma. The Food and Drug Administration (FDA) has approved Monjuvi ...